Search

everythinglearnresearchcommunity

for

Search:↓

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

ROS may affect hair loss related to hormones.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Age-related immune changes worsen Parkinson's disease, suggesting new treatment strategies.

Researchers found a way to create cells from stem cells that act like human cells important for hair growth and could be used for hair regeneration treatments.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Methadone may worsen liver fibrosis in males with HCV.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Gut bacteria affect female reproductive health and may help diagnose and treat related diseases.